Los Angeles Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$179K Buy
46,874
+17,354
+59% +$84K ﹤0.01% 1199
2026
Q1
$156K Buy
+29,520
New +$182K ﹤0.01% 1205
2025
Q3
– Sell
-25,428
Closed -$106K – 1551
2025
Q2
$106K Buy
+25,428
New +$159K ﹤0.01% 1251
2021
Q4
– Sell
-930
Closed -$34K – 1499
2021
Q3
$34K Hold
930
– – ﹤0.01% 1460
2021
Q2
$45K Sell
930
-5,470
-85% -$228K ﹤0.01% 1518
2021
Q1
$190K Buy
+6,400
New +$179K ﹤0.01% 1544

Other funds holding VSTM

Los Angeles Capital Management's VSTM Position: Q2 2026 in Review

Los Angeles Capital Management increased its Verastem (VSTM) stake by 59% in Q2 2026, buying an estimated $84K and bringing the position to 46,874 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Los Angeles Capital Management first reported a position in VSTM in Q1 2021 and has held it in 6 quarters since. The position peaked at $190K in Q1 2021. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Los Angeles Capital Management held 46,874 shares of Verastem worth $179K as of Q2 2026.
  • Los Angeles Capital Management bought 17,354 Verastem shares in Q2 2026, an estimated $84K.
  • Verastem made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1199 holding.
  • Los Angeles Capital Management first reported a position in Verastem in Q1 2021 and has held it in 6 quarters since.
  • Los Angeles Capital Management's Verastem position peaked at $190K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.